Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial - Marty, F M; Ljungman, P; Papanicolaou, G A (Lancet Infect Dis, 2011)
, et al; Maribavir 1263-300 Clinical Study Group.